to
possibly change the future of a disorder; in this case, it may come down to
just thirty patients and two researchers in Norway. The news that 2/3rds of
CFS patients taking a chemotherapy drug called Rituximab significantly
improved in a rigorous, double-blinded placebo controlled trial swept the
CFS community immediately and then medical websites.
Rituximab has been a kind of underground hope that=92s slowly been getting
stronger and stronger over time. Now with the successful trial it's hit th=
e
big time and more research should follow and quickly. Check out how this
study may very well alter how ME/CFS is both treated and percieved in
Treatment Breakthrough (and Paradigm Shift) For CFS? Rituximab Trial
Promises Hope
--=20
*
Cort Johnson
Phoenix Rising* - A non-profit 501(c)(3) charitable organization dedicated
to improving the lives of people with chronic fatigue syndrome (ME/CFS) and
other neuroendocrineimmune disorders
[image: Preview
Image]<https://www.paypal.com/cgi-bin/webscr?cmd=3D_s-xclick&hosted_button_=
id=3D5BL7MGLRCA2AC>
*
*
- *Website <http://aboutmecfs.org>*
- *Forums <http://forums.aboutmecfs.org>*
**
---------------------------------------------
Send posts to CO-CURE@listserv.nodak.edu
Unsubscribe at http://www.co-cure.org/unsub.htm
Co-Cure Archives: http://listserv.nodak.edu/archives/co-cure.html
---------------------------------------------
Co-Cure's purpose is to provide information from across the spectrum of
opinion concerning medical, research and political aspects of ME/CFS and/or
FMS. We take no position on the validity of any specific scientific or
political opinion expressed in Co-Cure posts, and we urge readers to
research the various opinions available before assuming any one
interpretation is definitive. The Co-Cure website <www.co-cure.org> has a
link to our complete archive of posts as well as articles of central
importance to the issues of our community.
---------------------------------------------
